Arrowhead Research Corp. (Nasdaq: ARWR) has sold subsidiary Aonex Technologies to AmberWave Systems, a Salem, N.H.-based provider of strained silicon technology for the semiconductor industry. The deal is valued at up to $7.95 million in earnouts.
Aonex is a Pasadena, Calif.-based developer of materials integration technology for the solar, LED and laser markets.
AmerWave has raised over $92 million in VC funding from firms like Arch Venture Partners, Hillman Ventures, Dow Chemical Co., 3i Group, Adams Capital Management and TeleSoft Partners.
Arrowhead Research Corporation announced today the sale of its majority-owned subsidiary, Aonex Technologies, to AmberWave Systems. Under the terms of the deal, AmberWave will pay Aonex shareholders up to $7.95M in earn-out payments, plus a running royalty on sales of solar products incorporating Aonex's technology.
Aonex Technologies was launched in 2004 by Arrowhead and Caltech Professor Dr. Harry Atwater to commercialize a materials integration technology developed in Dr. Atwater's lab for high efficiency solar cells. The Company later expanded its focus and product development efforts to address the growing LED and laser markets. Aonex's primary product is an innovative substrate that could enable the fabrication of higher efficiency compound semiconductor devices at lower cost and higher yields.
AmberWave Systems is a leader in the research and development of advanced materials technologies. AmberWave Systems focuses on methods for the integration of dissimilar semiconductor materials to enable high-performance devices at low manufacturing costs. Aonex's technology is expected to enhance AmberWave's existing technology portfolio and enable AmberWave to move into new, high-growth markets.
“AmberWave's technical capabilities and business expertise make it the perfect company to bring Aonex's products to market,” said Aonex CEO and co-founder Sean Olson. “There is a shared vision of using materials integration to develop better, more cost effective semiconductor devices.”
“The strong synergies between Aonex and AmberWave made selling Aonex the right decision,” said Chris Anzalone, CEO of Arrowhead. “AmberWave is well positioned to scale Aonex's prototypes and customer traction into compelling businesses in the optoelectronic and solar markets.”
As part of the acquisition, Aonex founder Dr. Harry Atwater, will continue to support the development of the technology. In addition, AmberWave will take over Aonex's
About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowres.com) (NASDAQ:ARWR) is a publicly-traded nanotechnology company commercializing new technologies in the areas of life sciences, electronics, and energy. Arrowhead is building value for shareholders through the progress of majority owned subsidiaries founded on nanotechnologies originally developed at universities. The company works closely with universities to source early stage deals and to generate rights to intellectual property covering promising new nanotechnologies. Currently, Arrowhead has four subsidiaries commercializing nanotech products and applications, including anti-cancer drugs, RNAi therapeutics, carbon-based electronics and compound semiconductor materials.
About Aonex Technologies
Aonex Technologies, Inc. is a developer of proprietary substrates that reduce the production cost of devices such as blue LEDs and high-efficiency solar cells. The Company is based in
About AmberWave Systems
Founded in 1998, AmberWave Systems has become a leader in the research, development and licensing of advanced technologies for semiconductor manufacturing. By funding and guiding university research, AmberWave Systems is bringing new technology developments to fruition through patents and technology licensing. In conjunction with its university research projects, AmberWave Systems conducts its own research, development and limited manufacturing in its semiconductor fabrication facility in